Albuterol HFA MDI in Pediatric Participants With Asthma

Study Title

Albuterol HFA MDI in Pediatric Participants With Asthma

Teva Identifier

IXR-302-25-105

ClinicalTrials.gov Identifier

NCT00577655

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Albuterol | Drug: Placebo | Drug: Proventilֲ® HFA

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations

Key Participation Requirements

Gender

Female, Male

Age Range

4 Years to 11 Years

Trial Duration

08/01/2007 - 07/01/2008

Phase

Phase 3

Study Type

Interventional